Xaira Therapeutics is seeking a Senior Scientist to architect and lead in vivo CRISPR screening efforts, spanning mouse models, data science, AI/ML, and translational biology. You will translate genetic screening insights into therapeutic discovery while balancing strategic
Xaira Therapeutics in the San Francisco Bay Area is seeking a Senior Scientist to architect and lead in vivo CRISPR screening efforts. You will push high-throughput functional genomics at the intersection of mouse biology, data science, AI/ML,
ArentFox Schiff, a leading law firm in San Francisco, is looking for a patent agent or attorney with at least five years of experience in biotechnology. Candidates must have a strong background in preparing and prosecuting
Xaira Therapeutics in the San Francisco Bay Area is seeking a Senior Scientist to architect and lead in vivo CRISPR screening. You will push high-throughput functional genomics at the intersection of mouse models, AI/ML, and translational biology
IT Engagements is partnering with a premium client to fill a Scientist II role in South San Francisco, CA. You will join a viral vector core, driving production, analytics, and development of next-generation vectors for gene
The Opportunity We are seeking a highly motivated, hands-on, and creative Scientist to advance research and drug discovery efforts within our Neuroscience team. In this role, you will lead the generation and application of complex iPSC-derived
The Opportunity We are seeking a highly motivated and collaborative Scientist 2, Neuroscience Discovery & iPSC Assay Development to advance discovery research and drug development efforts within our Neuroscience team. In this role, you will leverage
About Arc Institute Arc Institute is an independent nonprofit research organization at the interface of artificial intelligence and biology, working to accelerate scientific progress and understand the root causes of complex diseases. Founded in 2021 and
Our Mission Our mission is to restore cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life. For more information, see our website at altoslabs.com. Our Value
About Xaira Therapeutics Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling
Company Description About AbbVie AbbVies mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on
About Arc Institute Arc Institute is an independent nonprofit research organization at the interface of artificial intelligence and biology, working to accelerate scientific progress and understand the root causes of complex diseases. Founded in 2021 and
About Arc Institute Arc Institute is an independent nonprofit research organization at the interface of artificial intelligence and biology, working to accelerate scientific progress and understand the root causes of complex diseases. Founded in 2021 and
Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
About Arc Institute The Arc Institute is a new scientific institution conducting curiosity-driven basic science and technology development to understand and treat complex human diseases. Headquartered in Palo Alto, California, Arc is an independent research organization
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased
A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have
The Cell Therapy department within Genentech Research and Early Development (gRED) is seeking a motivated scientist to help develop novel cell therapies for patients with intractable diseases. We are looking for a highly collaborative, detail-oriented scientist